ALKERMES reported $356.33M in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
AbbVie USD 12.48B 1.56B Mar/2025
Acadia Pharmaceuticals USD 119.69M 5.97M Jun/2025
ALKERMES USD 356.33M 34.58M Jun/2025
Amgen USD 8.7B 569M Jun/2025
Biogen USD 2.08B 87.5M Jun/2025
BioMarin Pharmaceutical USD 855.85M 116.68M Jun/2025
Bristol-Myers Squibb USD 15.1B 515M Jun/2025
Eli Lilly USD 17.21B 3.2B Jun/2025
Gilead Sciences USD 4.78B 393M Jun/2025
Ionis Pharmaceuticals USD 52.58M 12.87M Jun/2025
J&J USD 16.02B 1.18B Mar/2025
Malin Corporation EUR 500K 300K Dec/2024
Merck USD 12.72B 1.14B Jun/2025
Neurocrine Biosciences USD 595.7M 79.7M Jun/2025
Otsuka Holdings JPY 504.41B 19.69B Jun/2025
Pfizer USD 16.09B 1.35B Jun/2025
Regeneron Pharmaceuticals USD 5.61B 49M Jun/2025
Vertex Pharmaceuticals USD 1.89B 88.4M Jun/2025